IDO1 and neoplasm: IDO inhibition in combination with a tumor vaccine was found to be able to convert suppressive Tregs into Th17-like cells in tumor draining lymph nodes of tumor-bearing mice, and this treatment both enhanced CD8 T cell activation and reduced tumor growth (57).